tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Vertex Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
The FlyVertex Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
8h ago
VRTX
Vertex Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Vertex Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
23h ago
VRTX
Vertex Pharmaceuticals price target raised to $462 from $459 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $462 from $459 at Morgan Stanley
13d ago
VRTX
Vertex Pharmaceuticals announces EC approval of expanded KAFTRIO label
PremiumThe Fly
Vertex Pharmaceuticals announces EC approval of expanded KAFTRIO label
15d ago
VRTX
Early notable gainers among liquid option names on April 4th
PremiumThe Fly
Early notable gainers among liquid option names on April 4th
18d ago
CHD
CLX
Vertex Pharmaceuticals price target raised to $420 from $408 at RBC Capital
PremiumThe FlyVertex Pharmaceuticals price target raised to $420 from $408 at RBC Capital
21d ago
VRTX
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
22d ago
DYN
MGX
Marks resignation ‘not good’ for biotech sector, says RBC
Premium
The Fly
Marks resignation ‘not good’ for biotech sector, says RBC
22d ago
DYN
RNA
Vertex Pharmaceuticals: Promising Growth Amid Setbacks with Strong Pipeline and Transformative Diabetes Program
PremiumRatings
Vertex Pharmaceuticals: Promising Growth Amid Setbacks with Strong Pipeline and Transformative Diabetes Program
22d ago
VRTX
Vertex Pharmaceuticals price target raised to $567 from $555 at BofA
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $567 from $555 at BofA
22d ago
VRTX
Vertex Pharmaceuticals’ Journavx: Strong Demand and Positive Outlook Drive Buy Rating
PremiumRatings
Vertex Pharmaceuticals’ Journavx: Strong Demand and Positive Outlook Drive Buy Rating
22d ago
VRTX
Vertex Pharmaceuticals: Advancements in T1D Program and Strategic Focus on Innovative Therapies Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Advancements in T1D Program and Strategic Focus on Innovative Therapies Justify Buy Rating
23d ago
VRTX
Vertex Pharmaceuticals: Strategic Advancements and Promising Market Potential Drive Buy Rating
PremiumRatingsVertex Pharmaceuticals: Strategic Advancements and Promising Market Potential Drive Buy Rating
24d ago
VRTX
Vertex Pharmaceuticals pursuing research-stage T1Dd programs
Premium
The Fly
Vertex Pharmaceuticals pursuing research-stage T1Dd programs
25d ago
VRTX
Vertex Pharmaceuticals says VX-264 study did not meet primary endpoint
Premium
The Fly
Vertex Pharmaceuticals says VX-264 study did not meet primary endpoint
25d ago
VRTX
Cautious Outlook on Vertex Pharmaceuticals’ Journavx Amid Market Penetration Challenges and Accessibility Concerns
PremiumRatings
Cautious Outlook on Vertex Pharmaceuticals’ Journavx Amid Market Penetration Challenges and Accessibility Concerns
1M ago
VRTX
Vertex Pharmaceuticals exec Altshuler sells 3,231 common shares
PremiumThe Fly
Vertex Pharmaceuticals exec Altshuler sells 3,231 common shares
1M ago
VRTX
MaxCyte price target lowered to $6 from $8 at BTIG
PremiumThe Fly
MaxCyte price target lowered to $6 from $8 at BTIG
1M ago
MXCT
VRTX
Vertex Pharmaceuticals announces MHRA approval of ALYFTREK for CF
PremiumThe Fly
Vertex Pharmaceuticals announces MHRA approval of ALYFTREK for CF
2M ago
VRTX
Vertex non-opioid pain drug picked up by UnitedHealth
PremiumThe FlyVertex non-opioid pain drug picked up by UnitedHealth
2M ago
UNH
VRTX
Vertex Pharmaceuticals: Buy Rating Driven by Outpatient Market Potential and Strategic Initiatives for Journavx
Premium
Ratings
Vertex Pharmaceuticals: Buy Rating Driven by Outpatient Market Potential and Strategic Initiatives for Journavx
2M ago
VRTX
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation
Premium
The Fly
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation
2M ago
SION
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >